By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Oncology/Immunology285.54M52.06%
Other Ventures262.97M47.94%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
People’s Republic of China (PRC)407.45M74.28%
US and Others141.06M25.72%